1-888-676-1157 (Mon-Fri 9am-5pm EST) info@somaleaf.com

Somaleaf CBD Turmeric - 2OZ Bottle


Somaleaf CBD Turmeric - 2OZ Three Bottles


Somaleaf CBD Turmeric - 2OZ Six Bottles


Save up to 25% on multi-bottle packs
1 Bottle
3 Bottles
Save 15%
6 Bottles
Save 25%
Due to local laws concerning the sale of hemp products, we are unable to sell to persons located in Idaho, Iowa, Nebraska, and North Dakota. Due to customs restrictions, we are currently unable to ship to Canada. Additionally, certain states have banned the sale of hemp edibles: Maine, New York, North Carolina, and Ohio. We appreciate your understanding.

CBD Turmeric: The Basics

SomaLeaf CBD Turmeric delivers you the highest quality ingredients in a highly bioavailable form. Each batch is tested for purity and potency, so you can be assured you are getting a clean product, which delivers the results you are looking for. Our patented liposomal technology ensures the active ingredients are readily available for absorption so you can benefit from all CBD and Turmeric have to offer.

Turmeric ancient medicinal use

Ingredients & Usage

Turmeric ancient history of medicinal use

Take 8 pumps of SomaLeaf Liposomal CBD Turmeric each night before bed (or throughout the day as needed).

Enjoy straight, under the tongue, in a small glass of water or mixed into an 8 oz. glass of juice. It can also be added to your favorite smoothie.

Gently shake before using.

CBD Turmeric nutrition label




* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. The website‘s content and the product for sale is based upon the author‘s opinion and is provided solely on an “AS IS” and “AS AVAILABLE” basis. You should do your own research and confirm the information with other sources when searching for information regarding health issues and always review the information carefully with your professional health-care provider before using any of the protocols presented on this website and/or in the product sold here. Neither SOMALEAF nor the author are engaged in rendering medical or similar professional services or advice via this website or in the product, and the information provided is not intended to replace medical advice offered by a physician or other licensed health-care provider.


  1. [1] Schiborr, C., Kocher, A., Behnam, D., Jandasek, J., Toelstede, S., & Frank, J. (2014, March). The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24402825
  2. [2] Grinspoon, P. (2019, August 27). Cannabidiol (CBD) – what we know and what we don’t. Retrieved from https://www.health.harvard.edu/blog/cannabidiol-cbd-what-we-know-and-what-we-dont-2018082414476
  3. [3] Bridgeman, M. B., & Abazia, D. T. (2017, March). Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312634/
  4. [4] HelloMD. (n.d.). Is Cannabidiol, or CBD, Really Non-Psychoactive? Retrieved from https://hellomd.com/blogs/articles/is-cannabidiol-or-cbd-really-non-psychoactive
  5. [5] A, N. /. (2019, August 8). 1 in 7 Adults Use CBD Products, Gallup Survey Finds. Retrieved from https://www.usnews.com/news/health-news/articles/2019-08-08/1-in-7-adults-use-cbd-products-gallup-survey-finds
  6. [6] Khan, M. I., Sobocińska, A. A., Czarnecka, A. M., Król, M., Botta, B., & Szczylik, C. (2016). The Therapeutic Aspects of the Endocannabinoid System (ECS) for Cancer and their Development: From Nature to Laboratory. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412000/
  7. [7] Zou, S., & Kumar, U. (2018, March 13). Cannabinoid Receptors and the Endocannabinoid System: Signaling and Function in the Central Nervous System. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877694/
  8. [8] Velasquez-manoff, M. (2019, May 15). Can CBD Really Do All That? Retrieved from https://www.nytimes.com/interactive/2019/05/14/magazine/cbd-cannabis-cure.html
  9. [9] Komorowski, J., & Stepień, H. (2007). The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/17369778
  10. [10] Jikomes, N. (2019, October 1). What is the endocannabinoid system and what is its role? Retrieved from https://www.leafly.ca/news/science-tech/what-is-the-endocannabinoid-system
  11. [11] How CBD Works. (2018, February 19). Retrieved from https://www.projectcbd.org/science/how-cbd-works
  12. [12] Scotter, E. L., Abood, M. E., & Glass, M. (2010, June). The endocannabinoid system as a target for the treatment of neurodegenerative disease. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931550/
  13. [13] Jikomes, N. (2019, November 14). CBD (cannabidiol): What does it do and how does it affect the brain & body? Retrieved from https://www.leafly.ca/news/cbd/what-does-cbd-do
  14. [14] Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., & Nagarkatti, M. (2009, October). Cannabinoids as novel anti-inflammatory drugs. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828614/
  15. [15] Bruni, N., Della Pepa, C., Oliaro-Bosso, S., Pessione, E., Gastaldi, D., & Dosio, F. (2018, September 27). Cannabinoid Delivery Systems for Pain and Inflammation Treatment. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222489/
  16. [16] B, E. M., S, M. M., M, J., & M, C. R. (2015, September 5). Cannabidiol as a Potential Treatment for Anxiety Disorders. Retrieved from https://link.springer.com/article/10.1007/s13311-015-0387-1
  17. [17] Villines, Z. (2018, July 27). CBD oil for anxiety: Research, benefits, and risks. Retrieved from https://www.medicalnewstoday.com/articles/319622#risks
  18. [18] Shannon, S., Lewis, N., Lee, H., & Hughes, S. (2019). Cannabidiol in Anxiety and Sleep: A Large Case Series. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6326553/
  19. [19] Vučković, S., Srebro, D., Vujović, K. S., Vučetić, Č., & Prostran, M. (2018, November 13). Cannabinoids and Pain: New Insights From Old Molecules. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277878/
  20. [20] Russo, E. B. (2008, February). Cannabinoids in the management of difficult to treat pain. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2503660/
  21. [21] Xiong, W., Cui, T., Cheng, K., Yang, F., Chen, S.-R., Willenbring, D., … Zhang, L. (2012, June 4). Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
  22. [22] Johnson, J. (2018, July 29). CBD oil for pain management: Effects, benefits, and uses. Retrieved from https://www.medicalnewstoday.com/articles/319475#benefits-for-pain
  23. [23] Parker, L. A., Rock, E. M., & Limebeer, C. L. (2011, August). Regulation of nausea and vomiting by cannabinoids. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
  24. [24] Dansinger, M. (2019, October 31). Can CBD Help Diabetes? Benefits, Side Effects, Research and More. Retrieved from https://www.webmd.com/diabetes/cbd-and-diabetes
  25. [25] Huestis, M. A. (2007, August). Human cannabinoid pharmacokinetics. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2689518/
  26. [26] Laura PyneCBDC Lead Researcher As a nature/natural-living enthusiast and professional writer/researcher. (2020, March 9). Is CBD Oil Legal? A 2020 State by State Legal Guide. Retrieved from https://www.cbdcentral.com/is-cbd-legal/
  27. [27]  Ujváry, I., & Hanuš, L. (2016, March 1). Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5576600/
  28. [28] Zgair, A., Wong, J. C., Lee, J. B., Mistry, J., Sivak, O., Wasan, K. M., … Gershkovich, P. (2016, August 15). Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009397/
  29. [29] Benzie IFF, Wachtel-Galor S, editors, Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition, (Boca Raton FL): CRC Press/Taylor & Francis; 2011, http://www.ncbi.nlm.nih.gov/books/NBK92752/.
  30. [30] Benzie IFF, Wachtel-Galor, Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edition.
  31. [31] Shrikant Mishra and Kalpana Palanivelu, The Effect of Turmeric on Alzheimer’s disease: An overview, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781139/
  32. [32] Aggarwal BB. Curcumin-free tumeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of tumeric. Mol Nutr Food Res. 2013; 57:1529-42.
  33. [33] Lopresti AL, Maes M. Turmeric for the Treatment of Major Depression: A Randomised, Double-Blind, Placebo Controlled Study. J Affect Disord. 2014 Oct;167:368-75. doi: 10.1016/j.jad.2014.06.001.
  34. [34] Chainani-Wu N. Safety and Anti-Inflammatory Activity of Curcumin: A Component of Turmeric (Curcuma Longa). J Altern Complement Med. 2003 Feb;9(1):161-8.
  35. [35] Kang Q, Chen A. Curcumin inhibits srebp-2 expression in activated hepatic stellate cells in vitro by reducing the activity of specificity protein-1. Endocrinology. 2009
  36. [36] Brand, E. J., & Zhao, Z. (2017, March 10). Cannabis in Chinese Medicine: Are Some Traditional Indications Referenced in Ancient Literature Related to Cannabinoids? Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345167/
  37. [37] I.Canna, Institut. (2013, March). Retrieved from https://www.institut-icanna.com/en/blog/23/Cannabis-from-the-perspective-of-Indian-Traditional-Medicine-Ayurveda
  38. [38] Jurenka, J. S. (2009, June). Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/19594223
  39. [39] Lal, B., Kapoor, A. K., Asthana, O. P., Agrawal, P. K., Prasad, R., Kumar, P., & Srimal, R. C. (1999, June). Efficacy of curcumin in the management of chronic anterior uveitis. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10404539
  40. [40] Takada, Y., Bhardwaj, A., Potdar, P., & Aggarwal, B. B. (2004, December 9). Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/15489888
  41. [41] Bisht S, Maitra A. Systemic Delivery of Curcumin: 21st century Solutions for an Ancient Conundrum. Curr Drug Discov Technol. 2009;6:192–199. doi: 10.2174/157016309789054933.
E-Commerce powered by UltraCart